Medicine and Dentistry
Pulmonary Hypertension
75%
Calcium Ion
40%
Arterial Smooth Muscle Cell
34%
Diabetes Mellitus
32%
Vascular Remodeling
32%
Smooth Muscle Cell
29%
Lung Vasoconstriction
26%
Endothelial Cell
26%
Pulmonary Artery
25%
Ion Channel
24%
Hypoxia
18%
Coronary Artery
15%
Pulmonary Artery Smooth Muscle Cell
13%
Mechanistic Target of Rapamycin
12%
Pulmonary Vascular Disease
12%
Lung Vascular Resistance
11%
Downregulation
11%
Blood Vessel Tone
11%
Upregulation
10%
Endothelial Function
10%
Cell Proliferation
10%
Platelet Derived Growth Factor Receptor
10%
Calcium Channel
9%
Protein Expression
9%
Endoplasmic reticulum
9%
Experimental Pulmonary Hypertension
8%
Hypoxia-Induced Pulmonary Hypertension
8%
Coronary Artery Dilatation
8%
Cation Channel
8%
Stromal Interaction Molecule 2
8%
Systolic Blood Pressure
8%
Cav1.2
8%
Cardiac Catheterization
8%
Smooth Muscle
8%
Streptozocin
8%
Afterload
8%
Neurotrophin Receptor P75
8%
Reactive Oxygen Species
8%
Fenfluramine
8%
Thyroid Hormone Receptor
8%
Thyroid Hormone
8%
Coronary Microvascular Dysfunction
8%
Sodium Glucose Cotransporter Inhibitor
8%
Hypoxic Pulmonary Vasoconstriction
8%
Calcium Sensing Receptor
8%
Platelet Derived Growth Factor
8%
Isotopes of Calcium
8%
Connexin 40
8%
Chloroquine
8%
Efferocytosis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Mouse
85%
Calcium Ion
83%
Hypoxia
37%
Vascular Remodeling
33%
Calcium Channel
32%
Hypoxia-Induced Pulmonary Hypertension
25%
Calcium Sensing Receptor
24%
Hypoxic Lung Vasoconstriction
16%
Diabetes Mellitus
16%
Protein P53
16%
Chloroquine
16%
Pulmonary Vascular Disease
13%
Mouse Model
12%
Mammalian Target of Rapamycin
12%
Stromal Interaction Molecule 2
11%
Channel Blocker
11%
Experimental Pulmonary Hypertension
10%
Dihydropyridine
10%
Potassium Channel
9%
Microangiopathy
8%
Ion Channel
8%
Cation Channel
8%
Potassium Ion
8%
Reactive Oxygen Metabolite
8%
Peripheral Vasodilating Agent
8%
Neurotrophin Receptor P75
8%
Non Insulin Dependent Diabetes Mellitus
8%
Fenfluramine
8%
Sodium Glucose Cotransporter Inhibitor
8%
Halofuginone
8%
Streptozotocin
8%
Connexin 40
8%
Receptor
7%
Nifedipine
6%
Canagliflozin
6%
Transgenic Mouse
5%
Keyphrases
Pulmonary Artery Smooth muscle Cells (PASMCs)
37%
Pulmonary Hypertension
36%
Pulmonary Arterial Hypertension
30%
Pulmonary Artery
26%
Voltage Dependence
19%
Ca2+ Channels
18%
Ca2+
16%
Cx40
16%
Reactive Oxygen Species
16%
Chronic Hypoxia
16%
Pathogenic Role
16%
Lung
15%
Pulmonary Vasoconstriction
14%
Hypoxia-induced Pulmonary Hypertension
12%
Endothelial Cells
11%
Mouse Lung
10%
Cytosolic Free Ca2+
10%
Ca2+ Concentration
10%
Experimental Pulmonary Hypertension
9%
Idiopathic Pulmonary Arterial Hypertension
9%
Platelet-derived Growth Factor Receptor (PDGFR)
9%
Mouse Model
9%
Pulmonary Microvascular Endothelial Cells (PMVECs)
8%
TRP Channels
8%
Right Heart Catheterization
8%
Functional Characterization
8%
Pulmonary Vasodilators
8%
Induced Gene
8%
Endothelium-dependent
8%
Mechanosensitive Ion Channels
8%
P75 Neurotrophin Receptor (p75NTR)
8%
Cav1.2
8%
Smooth muscle
8%
Pulmonary Artery Smooth muscle Cell Proliferation
8%
CALHM1
8%
Stromal Interaction Molecule 1 (STIM1)
8%
Divergent Effects
8%
Endothelial Cell Dysfunction
8%
TH Receptor
8%
Mammalian Target of Rapamycin (mTOR)
8%
Coronary Artery Endothelial Cells
8%
Gene Dysregulation
8%
Calcium-sensing Receptor (CaSR)
8%
STIM2
8%
Vascular Tension
8%
Platelet-derived Growth factor-BB (PDGF-BB)
8%
Human Antigen R
8%
Hypoxic Pulmonary Vasoconstriction
8%
Disease Severity
8%
Sodium-glucose Cotransporter Inhibitors
8%